EUROAPI Secures €130-150 Million Supply Contract in Animal Health Sector

EUROAPI announced it has signed a Contract Manufacturing Organization (CMO) agreement with a global animal health company. The deal, valued between €130 and 150 million, will span 2025-2029. EUROAPI will supply a key veterinary product as part of this collaboration.

Ludwig de Mot, CEO of EUROAPI, emphasized the significance of the contract, stating it secures the long-term supply of an essential chemical molecule for veterinary use. He indicated this agreement would be pivotal for the company's FOCUS-27 project sales trajectory.

EUROAPI's expertise in the animal health sector includes products such as hormones, prostaglandins, and complex synthesis molecules. The global animal health market is valued at $41.8 billion in 2023, expected to grow to $56.8 billion by 2030 at a CAGR of 4.5%.